TriangleHEALTH PROFESSIONAL · SOURCE READING
Chemotherapy, surgery, tandem cycles of myeloablative therapy and HSCT, radiation therapy, and dinutuximab, with GM-CSF and isotretinoin
Source: Neuroblastoma Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: April 28, 2025 · Captured 2026-09-09.
Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary.
Context: Treatment of High-Risk Neuroblastoma / Treatment Options for High-Risk Neuroblastoma
Treatment for patients with high-risk disease is generally divided into the following three phases:
Induction (includes chemotherapy and surgical resection).
Source links and citations
Consolidation (tandem cycles of myeloablative therapy and HSCT and radiation therapy to the site of the primary tumor and residual metastatic sites).
Source links and citations
Postconsolidation (immunotherapy with GM-CSF and isotretinoin therapy).
Source links and citations
Continue within this section
Preserved source evidence · Not medical advice